CClinicalTrials.gg
Not yet recruitingNCT06175364Updated Feb 29, 2024

Evidence-Based Orthotics Prosthetics Practices

An interventional study of Health Professionals in the Field of Orthotics Prosthetics in Evidence-Based Practice, sponsored by Medipol University. Not yet recruiting at 1 site in Turkey. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-02-29.

Sponsored by Medipol University · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Apr 2024, 2 years 5 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
134
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The main purpose of our research is; The aim of this study is to investigate the views of health professionals in the field of Orthotic Prosthesis in Turkey on Evidence-Based Orthotic Prosthesis Practices. This research is important in revealing the perspective of health professionals in this field on evidence-based orthotic prosthesis applications. No such study has been found in the literature in the field of Orthosis and Prosthesis. In this respect, it aims to bring a new perspective to the literature.

Read the detailed description

Three data collection tools will be used as data collection methods for the research. These data collection tools; demographic information form, Health Sciences Evidence-Based Practice Survey and Information Literacy Self-Efficacy Scale. Surveys will be sent to participants to be filled out via Google Forms.

Inclusion criteria: Having been working in hospitals, clinics, academic units, etc. in Turkey for at least 6 months. Being able to read and write Turkish. Exclusion criteria; Those who graduated in the field of Orthosis and Prosthesis and work in other clinics and units.

The data will be evaluated in the statistical package program IBM Statistical Package for the Social Sciences Statistics 26.0 (IBM Corp, New York, USA).

To determine the sample size in the study, G*Power 3.1.9.4 software was used to calculate the number of people to take part in the study. The effect size of the study was determined as 134 participants with 80% statistical power and 5% significance level. Our research will be conducted between December 2023 and June 2024.

02

Conditions studied

  • Evidence-Based Practice
03

In context

Lead sponsor

Medipol University is the lead sponsor of 311 studies on the registry; 86 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Inclusion Criteria: Having been working in hospitals, clinics, academic units, etc. in Turkey for at least 6 months.
  • Being able to read and write Turkish

Exclusion criteria

Exclusion Criteria:

  • Those who graduated in the field of Orthosis and Prosthesis and work in other clinics and units
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
134 participants (estimated)

Study arms

  • Other
    Health Professionals in the Field of Orthotics Prosthetics

    Health professionals in the field of orthotics and prosthetics generally include orthotic and prosthetic specialists, physiotherapists, rehabilitation specialists, orthopedic surgeons, biomechanics experts, physiologists, and engineers. These professionals specialize in the design, production, application, and rehabilitation of orthoses and prostheses.

    Other: Health Professionals in the Field of Orthotics Prosthetics

Interventions

  • OtherHealth Professionals in the Field of Orthotics Prosthetics

    Three data collection tools will be used as data collection methods for the research. These data collection tools; demographic information form, Health Sciences Evidence-Based Practice Survey and Information Literacy Self-Efficacy Scale.

06

What researchers measure

Primary outcomes

  1. Health Sciences Evidence-Based Practice Survey

    It is a form created to collect participants' information about evidence-based practices in health sciences. The survey is a 10-point Likert scale with a total of 60 items. Main; The scale consists of 3 subheadings: belief-attitude (12 items with total scores ranging from 12 to 120), practice (36 items with total scores ranging from 36 to 360) and barriers-facilitators (12 items with scores ranging from 12 to 120). A higher score indicates a more supportive attitude or behavior towards the implementation of evidence-based practices in clinical practice.

    Time frame: 2 weeks

07

Study locations

1 site
  • Istanbul Medipol University
    Istanbul, Turkey
    • Medipol Universitesi · Contact
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 29, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06175364
Lead sponsor
Medipol University
Responsible party
Alican AK (Principal Investigator, Medipol University) — Principal investigator
First posted
Dec 18, 2023
Start date
Mar 15, 2024 (estimated)
Primary completion
Apr 15, 2024 (estimated)
Completion
May 15, 2024 (estimated)
Last update
Feb 29, 2024

Study contacts

alican ak
Contact
alican.ak@outlook.com
+905549239227
Gizem BOZTAŞ ELVERİŞLİ, Dr.Öğr.Üye.
study director · MedipolIU

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion